UK based global companies – The Milli Chronicle

Thursday, October 2, 2025

Latest:

Google Steps Up Cybersecurity Vigilance as Hackers Target Executives with Extortion Emails
ECB partners with Portuguese AI startup to safeguard future digital euro
AstraZeneca’s Dual Listing in New York Boosts Global Reach While Strengthening London’s Financial Future
Ali Akbar, Paris’ Legendary Newspaper Hawker, Becomes a Living Symbol of Dedication and Joy
Ancient AlUla Treasures Take Center Stage in China, Celebrating Millennia of Cultural Exchange

Featured News World

NewsDesk Milli Chronicle October 2, 2025 AstraZeneca balanced strategy, AstraZeneca cardiovascular medicines, AstraZeneca drug innovation, AstraZeneca dual listing, AstraZeneca future growth., AstraZeneca global expansion, AstraZeneca global vision, AstraZeneca innovation funding, AstraZeneca investor confidence, AstraZeneca London Stock Exchange, AstraZeneca market capitalization, AstraZeneca New York Stock Exchange, AstraZeneca oncology research, AstraZeneca revenue growth, AstraZeneca shareholder value, AstraZeneca Stockholm listing, AstraZeneca US investors, AstraZeneca vaccines, British business resilience, British financial markets, British headquartered companies, FTSE 100 companies, global healthcare leadership, global pharmaceutical company, international capital markets, London and New York financial markets, London as financial hub, London Stock Exchange strength, UK based global companies, UK corporate governance, UK economy confidence, UK government business support

AstraZeneca’s Dual Listing in New York Boosts Global Reach While Strengthening London’s Financial Future

AstraZeneca’s decision to list in New York while retaining its strong London base signals confidence in the UK economy and